Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease

Abstract

Patients with lower burden of ICBs and other psychiatric symptomatology, better social functioning, and lower dose of antiparkinsonian medication may benefit more from CBT. However, we cannot yet identify individual patients with sufficient confidence at this stage to target treatment.